Amoxicillin in infections in patients with cancer.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009504:Neutrophils; D010403:Penicillin Resistance; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D011513:Proteus mirabilis / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D000588:Amines; D010406:Penicillins